LOBENZARIT SODIUM

Details

Stereochemistry	ACHIRAL
Molecular Formula	C14H8ClNO4.2Na
Molecular Weight	335.65
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

[Na+].[Na+].[O-]C(=O)C1=CC=CC=C1NC2=CC(Cl)=CC=C2C([O-])=O

InChI

InChIKey=QPJBONAWFAURGB-UHFFFAOYSA-L

InChI=1S/C14H10ClNO4.2Na/c15-8-5-6-10(14(19)20)12(7-8)16-11-4-2-1-3-9(11)13(17)18;;/h1-7,16H,(H,17,18)(H,19,20);;/q;2*+1/p-2

HIDE SMILES / InChI

Molecular Formula	C14H8ClNO4
Molecular Weight	289.671
Charge	-2
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Molecular Formula	Na
Molecular Weight	22.98976928
Charge	1
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Description
Sources: https://chugai-pharm.jp/hc/ss/pr/drug/car_fil0080/shiori/PDF/en/car_s_en.pdf
Curator's Comment: description was created based on several sources, including: https://www.ncbi.nlm.nih.gov/pubmed/9161931 | http://www.rad-ar.or.jp/siori/english/kekka.cgi?n=750

Lobenzarit is an immunomodulator and antioxidative agent, which has been used successfully in Japan for the treatment of rheumatoid arthritis. Lobenzarit is a scavenger of oxygen-free radicals such as hydroxyl radicals, superoxide, peroxyl and singlet oxygen. Side effects of this medicine are: decreased/considerably increased urinary volume, bloody urine, frequent urination.

Originator

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
Glutathione reductase, mitochondrial 4 Target ID: P00390 Gene ID: 2936.0 Gene Symbol: GSR Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/8748682 \| https://www.ncbi.nlm.nih.gov/pubmed/8285143	Activator 1447
Glutathione S-transferases (rat) 2 Target ID: Glutathione S-transferases (rat) Sources: https://www.ncbi.nlm.nih.gov/pubmed/8748682	Inhibitor 8504
response to oxidative stress 20 Target ID: GO:0006979 Sources: https://www.ncbi.nlm.nih.gov/pubmed/9161931	Modulator 846

Conditions

Condition	Modality	Targets	Highest Phase	Product
Chronic rheumatoid arthritis 4 Sources: https://chugai-pharm.jp/hc/ss/pr/drug/car_fil0080/shiori/PDF/en/car_s_en.pdf https://chugai-pharm.jp/hc/ss/pr/drug/car_fil0040/if/PDF/car_if.pdf	Primary		Approved 8583	CARFENIL Approved Use This medicine improves immune abnormality and reduces inflammation and swelling of joints and so on. It is usually used to treat chronic rheumatoid arthritis. Launch Date 1986

PubMed

Title	Date	PubMed
Estimation of the percolation thresholds in ternary lobenzarit disodium-dextran-HPMC hydrophilic matrices tablets: effects of initial porosity.	2009-11-05	19666114
Estimation of the percolation thresholds in lobenzarit disodium native dextran matrix tablets.	2007-12-28	18181536
Investigation of the influence of particle size on the excipient percolation thresholds of HPMC hydrophilic matrix tablets.	2007-10	17506514
Study of the critical points in lobenzarit disodium hydrophilic matrices for controlled drug delivery.	2006-05	16651752
Drugs to treat inflammation: a historical introduction.	2005	16378496
Application of a new mathematical method for the estimation of the mean surface area to calculate the percolation threshold of lobenzarit disodium [correction of dissodium] salt in controlled release matrices.	2004-07	15256698
Alpha-methyldopa-type autoimmune hemolytic anemia caused by lobenzarit disodium of a mefenamic acid derivative and immunomodulator.	1994-05-15	8180406

Patents

Sample Use Guides

In Vivo Use Guide

2 tablets (80 mg of the active ingredient) at a time, 3 times a day, in combination with other antiphlogistic analgesic

Route of Administration: Oral

In Vitro Use Guide

The Iobenzarit at concentrations of 1, 30, 100 and 1000 uM Iobenzarit had no inhibitory effect on various rat liver microsomal P-450 activities: on the ethoxyresorufin O-dealkylation activity, on the pentoxyresorufin O-deaikylation activity or on the p-nitrophenol hydroxylation activity, when measured in liver microsomes isolated from rats induced with beta-naphthoflavone, phenobarbital and pyrazol.

Substance Class	Chemical Created by `admin` on `Mon Mar 31 18:13:21 GMT 2025` Edited by `admin` on `Mon Mar 31 18:13:21 GMT 2025`
Record UNII	7Z9SP74BXF
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

CARFENIL

Preferred Name

English

LOBENZARIT SODIUM

Official Name

English

LOBENZARIT SODIUM [USAN]

Common Name

English

LOBENZARIT DISODIUM SALT

Common Name

English

LOBENZARIT DISODIUM

Common Name

English

BENZOIC ACID, 2-((2-CARBOXYPHENYL)AMINO)-4-CHLORO-, DISODIUM SALT

Common Name

English

LOBENZARIT SODIUM [MART.]

Common Name

English

LOBENZARIT SODIUM [JAN]

Common Name

English

Lobenzarit sodium [WHO-DD]

Common Name

English

DISODIUM 4-CHLORO-2,2'-IMINODIBENZOATE

Systematic Name

English

LOBENZARIT DISODIUM SALT [MI]

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C257